Gluetacs Therapeutics
格博生物
Gluetacs Therapeutics
Biotech/Healthcare
Gebo Biotechnology is a biotechnology company focused on developing small-molecule innovative targeted protein degraders. For disease-causing protein targets previously considered “undruggable,” it is developing next-generation molecular glues and PROTAC drugs for targeted protein degradation.
Latest round: Series A Extension (2022)
Source: ChinaBulls — chinabulls.com
Last updated 2022-08-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.